ASHLEY JOHNSON: Open Payments
NPI 1881956027 · MT STERLING, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,854 in 116 payments from 23 companies in 2025. Trend: 2023 $824 · 2024 $1,275 · 2025 $1,854
Food & beverage: $1,854
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $232 |
| GlaxoSmithKline, LLC. | 15 | $231 |
| Lilly USA, LLC | 11 | $229 |
| ABBVIE INC. | 30 | $206 |
| Novo Nordisk Inc | 10 | $184 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $138 |
| PFIZER INC. | 7 | $113 |
| Amgen Inc. | 3 | $63 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Dexcom, Inc. | 2 | $54 |
Products named: TRELEGY ELLIPTA, VRAYLAR, JARDIANCE, FARXIGA, CAPLYTA, NURTEC ODT, Wegovy, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
